The ZEUS (Zio ECG Utilization Software) system for iRhythm’s Zio Watch detects and characterizes atrial fibrillation over time to aid doctors in diagnosing the condition. The company expects to begin commercializing it next year.
[Editor's Note: This article was updated on 26 July to clarify which parts of the ZEUS system for iRhythm's Zio Watch were developed by Verily and iRhythm, respectively.]
The US Food and Drug Administration cleared the ZEUS (Zio Electrocardiogram Utilization Software) system for iRhythm’s Zio Watch, a...
Create an account to read this article
Already a subscriber?
Barcelona-based INBRAIN Neuroelectronics is partnering with Mayo Clinic to test whether its graphene-based cortical brain computer interface can enhance standard DBS in Parkinson’s, aiming for more precise adaptive therapy and improved gait outcomes.
A Sept. 17 panel at LSX in Boston discussed how brain-computer interface devices (BCIs) work, potential applications for BCIs, partnership, the investment landscape, ethical considerations and the five to 10-year outlook for the neurotech sector.
About 30% of providers flagged cybersecurity and data privacy as concerns while 40% pointed to patient engagement platforms as a challenge. By contrast, only 10% of respondents viewed AI and Gen AI applications or critical system upgrades as urgent priorities.
The US FDA will hold a public meeting of its Digital Health Advisory Committee in November to focus on generative AI-enabled medical devices to treat mental health.
The US FDA has approved Medtronic’s Altaviva, a subcutaneous device implanted near the ankle that offers a new treatment option for adults with urge urinary incontinence.
An interactive look at recent executive-level company changes and promotions in the medical device and diagnostics industries.
The new ESC and EACTS guidelines allow aortic stenosis patients without symptoms to be considered for a transcatheter aortic valve replacement. The move opens the market for Edwards Lifesciences, the only medtech with a Europe and US-approved device for asymptomatic severe aortic stenosis.
